-
Reigning world champs Tinch, Hocker among Millrose winners
-
Venezuelan activist ends '1,675 days' of suffering in prison
-
Real Madrid scrape win over Rayo, Athletic claim derby draw
-
PSG beat Strasbourg after Hakimi red to retake top spot in Ligue 1
-
NFL Cardinals hire Rams' assistant LaFleur as head coach
-
Arsenal scoop $2m prize for winning FIFA Women's Champions Cup
-
Atletico agree deal to sign Lookman from Atalanta
-
Real Madrid's Bellingham set for month out with hamstring injury
-
Man City won't surrender in title race: Guardiola
-
Korda captures weather-shortened LPGA season opener
-
Czechs rally to back president locking horns with government
-
Prominent Venezuelan activist released after over four years in jail
-
Emery riled by 'unfair' VAR call as Villa's title hopes fade
-
Guirassy double helps Dortmund move six points behind Bayern
-
Nigeria's president pays tribute to Fela Kuti after Grammys Award
-
Inter eight clear after win at Cremonese marred by fans' flare flinging
-
England underline World Cup
credentials with series win over Sri Lanka
-
Guirassy brace helps Dortmund move six behind Bayern
-
Man City held by Solanke stunner, Sesko delivers 'best feeling' for Man Utd
-
'Send Help' debuts atop N.America box office
-
Ukraine war talks delayed to Wednesday, says Zelensky
-
Iguanas fall from trees in Florida as icy weather bites southern US
-
Carrick revels in 'best feeling' after Man Utd leave it late
-
Olympic chiefs admit 'still work to do' on main ice hockey venue
-
Pope says Winter Olympics 'rekindle hope' for world peace
-
Last-gasp Demirovic strike sends Stuttgart fourth
-
Sesko strikes to rescue Man Utd, Villa beaten by Brentford
-
'At least 200' feared dead in DR Congo landslide: government
-
Coventry says 'sad' about ICE, Wasserman 'distractions' before Olympics
-
In-form Lyon make it 10 wins in a row
-
Man Utd strike late as Carrick extends perfect start in Fulham thriller
-
Van der Poel romps to record eighth cyclo-cross world title
-
Mbappe penalty earns Real Madrid late win over nine-man Rayo
-
Resurgent Pakistan seal T20 sweep of Australia
-
Fiji top sevens standings after comeback win in Singapore
-
Alcaraz sweeps past Djokovic to win 'dream' Australian Open
-
Death toll from Swiss New Year bar fire rises to 41
-
Alcaraz says Nadal inspired him to 'special' Australian Open title
-
Pakistan seeks out perpetrators after deadly separatist attacks
-
Ukraine war talks delayed to Wednesday, Zelensky says
-
Djokovic says 'been a great ride' after Melbourne final loss
-
Von Allmen storms to downhill win in final Olympic tune-up
-
Carlos Alcaraz: tennis history-maker with shades of Federer
-
Alcaraz sweeps past Djokovic to win maiden Australian Open title
-
Israel says partially reopening Gaza's Rafah crossing
-
French IT giant Capgemini to sell US subsidiary after row over ICE links
-
Iran's Khamenei likens protests to 'coup', warns of regional war
-
New Epstein accuser claims sexual encounter with ex-prince Andrew: report
-
Italy's extrovert Olympic icon Alberto Tomba insists he is 'shy guy'
-
Chloe Kim goes for unprecedented snowboard halfpipe Olympic treble
What is microRNA? Nobel-winning discovery explained
The Nobel Prize in Medicine was awarded on Monday to two US scientists for discovering microRNA, a previously unknown type of genetic switch which is hoped can pave the way for new medical breakthroughs.
But while several treatments and tests are under development using microRNAs against cancer, heart disease, viruses and other illnesses, none have actually yet reached patients.
And the world paid little attention when the new Nobel laureates Victor Ambros and Gary Ruvkun revealed their discovery decades ago, thinking it was just "something weird about worms", Cambridge University geneticist Eric Miska told AFP.
Here is an explainer about how exactly these tiny genetic switches work inside our bodies.
- What is microRNA? -
Each cell in the human body has the same set of instructions, called DNA. Some turn into brain cells, while others become muscles.
So how do the cells know what to become? The relevant part of the DNA's instructions is pointed to via a process called gene regulation.
Ribonucleic acid (RNA) normally serves as a messenger. It delivers the instructions from the DNA to proteins, which are the building blocks of life that turn cells into brains -- or muscles.
Miska gave the example of the messenger RNA vaccines rolled out against Covid-19 during the pandemic, which insert a message with new instructions to build proteins that block viruses.
But the two new Nobel winners Ambros and Ruvkun discovered a whole new type of gene regulator that had previously been overlooked by science.
Rather than being the messenger which relays information, microRNA instead acts as a switch to turn other genes off and on.
"This was a whole new level of control that we had totally missed," said Miska, who has worked on microRNA for two decades, including with the new Nobel laureates.
"The discovery of microRNAs brought an additional level of complexity by revealing that regions that were thought to be non-coding play a role in gene regulation," French researcher Benoit Ballester told AFP.
- What did the Nobel winners do? -
Back in the 1980s, Ambros and Ruvkun had been working separately on how genes interact in one-millimetre-long roundworms called C.elegans.
When they compared their work, it led to the discovery of microRNA. Ambros revealed the finding in a 1993 paper.
"Nobody really paid much attention," Miska said, explaining that most scientists at the time thought it only applied to worms.
Then in 2000, Ruvkun published research showing that microRNA is present right across the animal kingdom, including in humans and even some viruses.
"This was not just something weird that worms do, but in fact all animals and plants are totally dependent for development and normal function on them," Miska said.
More than a thousand genes that respond to microRNAs are now believed to be in the human body.
- How could this help us? -
There are numerous new treatments and tests using microRNA that are undergoing trials but none have been made widely available.
"Though there are no very clear applications available yet in microRNAs, understanding them, knowing that they exist, understanding their counter-regulatory networks, is always the first step," the Karolinska Institute's Gunilla Karlsson Hedestam told journalists in Stockholm.
MicroRNAs are particularly promising for fighting cancer because some of these switches "act as a tumour suppressor, so they put a brake on cells dividing inappropriately," Miska said.
Others, meanwhile, induce "cells to divide, which can lead to cancer", he added.
Because many viruses use microRNAs, several antiviral drugs are at varying stages of development, including for hepatitis C.
One complicating factor has been that microRNAs can be unstable.
But scientists also hope they can be used as a test called a "biomarker", which could reveal what type of cancer a patient could be suffering from, for example.
- What next? -
It also appears probable that microRNAs could be involved in the evolution of our species, Miska said.
While human brains are difficult to study, Miska hoped future research will discover more.
O.Lorenz--BTB